In the latest trading session, 0.62 million Heron Therapeutics Inc (NASDAQ:HRTX) shares changed hands as the company’s beta touched 1.70. With the company’s most recent per share price at $2.73 changing hands around $0.12 or 4.79% at last look, the market valuation stands at $412.00M. HRTX’s current price is a discount, trading about -17.95% off its 52-week high of $3.22. The share price had its 52-week low at $0.50, which suggests the last value was 81.68% up since then. When we look at Heron Therapeutics Inc’s average trading volume, we note the 3-month average coming to 2.23 million.
Heron Therapeutics Inc (NASDAQ:HRTX) trade information
Instantly HRTX is in green as seen in intraday trades today. With action 9.40%, the performance over the past five days has been green. The jump to weekly highs of 2.79 added 4.79% to the stock’s daily price. The company’s shares are showing year-to-date upside of 60.88%, with the 5-day performance at 9.40% in the green. However, in the 30-day time frame, Heron Therapeutics Inc (NASDAQ:HRTX) is -0.55% down.
Heron Therapeutics Inc (HRTX) estimates and forecasts
Data shows that the Heron Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 312.58% over the past 6 months, a 70.00% in annual growth rate that is considerably higher than the industry average of 11.70%. Year-over-year growth is forecast to reach 14.00% up from the last financial year.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 32.97M. 4 analysts are of the opinion that Heron Therapeutics Inc’s revenue for the current quarter will be 34.52M. The company’s revenue for the corresponding quarters a year ago was 29.61M and 31.76M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 11.30%. The estimates for the next quarter sales put growth at 8.70%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 20.01%. The 2024 estimates are for Heron Therapeutics Inc earnings to increase by 71.29%, but the outlook for the next 5-year period is at 47.50% per year.
